Valbiotis (XPAR:ALVAL) Valuation Rank

View and export this data going back to 2017. Start your Free Trial

What is Valbiotis Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Valbiotis Valuation Rank Related Terms

Thank you for viewing the detailed overview of Valbiotis's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Valbiotis (XPAR:ALVAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (XPAR:ALVAL) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

8JD:Germany

Address

12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180

Website

http://www.valbiotis.com

Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.